---
$id: https://graph.org.ai/products/commodity/51271906
$type: Product
source: UNSPSC
code: "51271906"
title: "Butacaine"
class: "51271900"
classTitle: "Anaesthetic aminobenzoates"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butacaine

**UNSPSC Code**: 51271906
**Class**: [Anaesthetic aminobenzoates](Anaesthetic aminobenzoates.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C18H30N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z84S23CGJJ, chemically known as 1-propanol, 3-(dibutylamino)-, p-aminobenzoate (ester) but generally known as butacaine, which bears US NIH Compound Identifier 2480. Butacaine most often comes in base, acetate, chloride, hydrochloride, and sulfate forms. European Medicines Agency schedules Butacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05994MIG. The term BUTACAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). BUTACAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butacaine under HS 29224995 and SITC 51465. As of Q4 2014, BUTACAINE remains the US FDA Preferred Term for this commodity. Butacaine bears US NLM identifiers UMLS ID C0006466 and NCI Concept Code C87457. SMILES: O(CCCN(CCCC)CCCC)C(=O)C1CCC(N)CC1.

